Only 25 percent of interviewed ambulatory providers report that meaningful use is having a positive impact on patient care.

September 10, 2014 — The U.S. Food and Drug Administration (FDA) reports it has revoked the Mammography Quality Standards Act (MQSA) certificate for Advanced Diagnostic Inc., a facility at 2300 W. Peterson Ave. in Chicago. The facility has ceased performing mammography.

September 9, 2014 — An experimental regimen of once-weekly breast irradiation following lumpectomy provides more convenience to patients at a lower cost, results in better completion rates of prescribed radiation treatment, and produces cosmetic outcomes comparable to the current standard of daily radiation. These interim results of the five-year Phase II clinical trial using the experimental regimen were presented at the Breast Cancer Symposium 2014 in San Francisco by Anthony E. Dragun, M.D., vice chair and associate professor of radiation oncology at the University of Louisville.

Community Health Centers (CHCs) across the country, which are the medical home for one in 15 people in the United States, are experiencing an overall increase in patients but fewer uninsured patients in 2014, according to a survey conducted by Direct Relief at the National Association of Community Health Centers (NACHC) annual conference last week. ?

September 8, 2014 — Mevion Medical Systems announced that MedStar Georgetown University Hospital has received final approval to begin construction of the first proton therapy center in Washington, D.C., at its Lombardi Comprehensive Cancer Center.

In community-based radiology practice, mammography screening with 3-D digital breast tomosynthesis (DBT) yielded lower recall rates, an increased overall cancer detection rate and an increased detection rate for invasive cancer compared with 2-D digital mammography (DM).